PTPRJ and idiopathic pulmonary fibrosis: Tsoyi et al. [121] found that silencing of CD148 can increase the production of the ECM and enhance the resistance to apoptosis in human IPF lung Fbs, whereas the overexpression of CD148 can improve pulmonary fibrosis; therefore, the activation of CD148 can play a certain role in anti-fibrosis.